BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38003406)

  • 1. Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ.
    Barbeau S; Semprez F; Dobbertin A; Merriadec L; Roussange F; Eymard B; Sternberg D; Fournier E; Karasoy H; Martinat C; Legay C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental consequences of the ColQ/MuSK interactions.
    Karmouch J; Dobbertin A; Sigoillot S; Legay C
    Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
    Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.
    Legay C
    Ann N Y Acad Sci; 2018 Feb; 1413(1):104-110. PubMed ID: 29405353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
    Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
    Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
    Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
    Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
    Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
    J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome.
    Rinz CJ; Levine J; Minor KM; Humphries HD; Lara R; Starr-Moss AN; Guo LT; Williams DC; Shelton GD; Clark LA
    PLoS One; 2014; 9(8):e106425. PubMed ID: 25166616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
    Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature.
    El Kadiri Y; Ratbi I; Sefiani A; Lyahyai J
    BMC Neurol; 2022 Aug; 22(1):292. PubMed ID: 35932018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation.
    Tsai KL; Vernau KM; Winger K; Zwueste DM; Sturges BK; Knipe M; Williams DC; Anderson KJ; Evans JM; Guo LT; Clark LA; Shelton GD
    J Vet Intern Med; 2020 Jan; 34(1):258-265. PubMed ID: 31769119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic basal lamina-associated congenital myasthenic syndromes.
    Maselli RA; Arredondo J; Ferns MJ; Wollmann RL
    Ann N Y Acad Sci; 2012 Dec; 1275():36-48. PubMed ID: 23278576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis.
    Ohno K; Ito M; Kawakami Y; Ohtsuka K
    J Mol Neurosci; 2014 Jul; 53(3):359-61. PubMed ID: 24234034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COLQ-related congenital myasthenic syndrome: An integrative view.
    Eshaghian T; Rabbani B; Badv RS; Mikaeeli S; Gharib B; Iyadurai S; Mahdieh N
    Neurogenetics; 2023 Jul; 24(3):189-200. PubMed ID: 37231228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of collagen Q in MuSK antibody-positive myasthenia gravis.
    Ohno K; Otsuka K; Ito M
    Chem Biol Interact; 2016 Nov; 259(Pt B):266-270. PubMed ID: 27119269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.
    Ishigaki K; Nicolle D; Krejci E; Leroy JP; Koenig J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2003 Mar; 13(3):236-44. PubMed ID: 12609505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.